Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Baijin Life Science Holdings's Revenue for the
six
months ended in Sep. 2025 was $7.08 Mil. Baijin Life Science Holdings's average Accounts Receivable for the
six
months ended in Sep. 2025 was $2.85 Mil.
Hence, Baijin Life Science Holdings's Receivables Turnover for the
six
months ended in Sep. 2025 was 2.49.
Baijin Life Science Holdings (OTCPK:MNNGF) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Baijin Life Science Holdings Receivables Turnover Related Terms
Baijin Life Science Holdings Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baijin Life Science Holdings Receivables Turnover Chart
For the Luxury Goods subindustry, Baijin Life Science Holdings's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baijin Life Science Holdings Receivables Turnover vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Baijin Life Science Holdings's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baijin Life Science Holdings (MNNGF) has a Receivables Turnover of 2.49 as of Sep. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Baijin Life Science Holdings and its competitors. According to the industry distribution chart, Baijin Life Science Holdings ranks #968 out of 1101 companies in the Retail - Cyclical industry, placing it in the top 87.9%.
Is Baijin Life Science Holdings' Receivables Turnover too high?
Baijin Life Science Holdings' current Receivables Turnover is 2.49. The Retail - Cyclical industry median Receivables Turnover is 19.36. Baijin Life Science Holdings' value of 2.49 is 87.1% below this industry median. Based on the distribution chart, Baijin Life Science Holdings ranks #968 out of 1101 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Baijin Life Science Holdings has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' Receivables Turnover compare to TPR?
According to the Retail - Cyclical industry distribution chart, Baijin Life Science Holdings ranks #968 out of 1101 companies for Receivables Turnover. This places Baijin Life Science Holdings in the lower half of its industry. The industry median Receivables Turnover is 19.36. Baijin Life Science Holdings' value of 2.49 is 87.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Retail - Cyclical company?
The median Receivables Turnover among Retail - Cyclical companies is 19.36, based on 1,101 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baijin Life Science Holdings's current Receivables Turnover of 2.49 is 87.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Baijin Life Science Holdings and its competitors. For the Retail - Cyclical industry, the median Receivables Turnover is 19.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baijin Life Science Holdings's current Receivables Turnover is 2.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current Receivables Turnover of 2.49. The stock's GF Value™ is $0.05, compared to a current price of $0.08 — trading 50% above its estimated fair value. The current Receivables Turnover is 2.49 and 87.1% below the Retail - Cyclical industry median of 19.36. Baijin Life Science Holdings' overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current Receivables Turnover is 2.49 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?
Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued.
The current stock price of $0.08 is trading 50% above its estimated GF Value™ of $0.05.
Key valuation signals for MNNGF:
Receivables Turnover: 2.49
GF Value™: $0.05 vs. price of $0.08 (50% above fair value)
Industry Position: 87.1% below the Retail - Cyclical median (#968 of 1101)
No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
26GF Score
Get the complete analysis for MNNGF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNNGF has been successfully added to your 
